Changes

Jump to navigation Jump to search
no edit summary
In practice, the third law states that when a new phenomenon is discovered, this discovery produces an abstract requirement to take that discovery into account when testing relevant theories. This abstract requirement is then specified by a new employed method.
 
The evolution of the drug trial methods is an example of the third law in action. For example, the discovery of the placebo effect in drug testing demonstrates that fake treatment can cause improvement in patient symptoms. As a result of its discovery the abstract requirement of “when assessing a drug’s efficacy, the possible placebo effect must be taken into account” was generated. This abstract requirement is, by definition, an accepted theory which stipulates that, if ignored, substantial doubt would be cast on any trial. As a result of this new theory, the Single-Blind Trial method was devised. The currently employed method in drug testing is the Double-Blind Trial, a method which specifies all of the abstract requirements of its predecessors. It is an apt illustration of how new methods are generated through the acceptance of new theories, as well as how new methods employ the abstract requirements of their predecessors.[[CiteRef::Barseghyan (2015)|pp. 132-152]]
The third law does not stipulate how methods should go about specifying any new abstract requirement. The third law functions as a descriptive account of how methods change, and is not responsible for describing how methods ought to change. As such, it is an effective means of explicating the requirements of other employed methods. The Aristotelian-Medieval method is one such example of its utility.
|VideoDescription=The third law explained by Hakob Barseghyan
|VideoEmbedSection=Description
}}
{{Theory Example
|Title=Drug Trial Methods
|Description=Barseghyan presents the example of testing a new drug for alleviating depression to as an example of the third law. In summary, the evolution of the drug trial methods is an example of the third law in action. For example, the discovery of the placebo effect in drug testing demonstrates that fake treatment can cause improvement in patient symptoms. As a result of its discovery the abstract requirement of “when assessing a drug’s efficacy, the possible placebo effect must be taken into account” was generated. This abstract requirement is, by definition, an accepted theory which stipulates that, if ignored, substantial doubt would be cast on any trial. As a result of this new theory, the Single-Blind Trial method was devised. The currently employed method in drug testing is the Double-Blind Trial, a method which specifies all of the abstract requirements of its predecessors. It is an apt illustration of how new methods are generated through the acceptance of new theories, as well as how new methods employ the abstract requirements of their predecessors.[[CiteRef::Barseghyan (2015)|pp. 132-152]]
 
Specifically, Barseghyan begins with the question "How can we ensure that the improvement was due to the drug itself and not due to other unaccounted factors?" The question is answered by the implementation of a ''controlled trial'', wherein "we organize a trial with two groups of patients with the same condition – the active group and the control group. Only the patients in the active group receive the drug".[[CiteRef::Barseghyan (2015)|pp. 133]]
 
<blockquote>What we have here is a transition from one method to another triggered by a new piece of knowledge about the world. The initial method was something along the lines of hypothetico-deductivism: we had a hypothesis “the drug is effective in alleviating depression” and we wanted to confirm it experimentally. Once we learnt that the alleviation may be due to other factors, our initial method was modified to require that a drug’s efficacy must be tested in a controlled trial.</blockquote>
|Example Type=Historical
}}
{{Acceptance Record

Navigation menu